We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03585465
Recruitment Status : Recruiting
First Posted : July 13, 2018
Last Update Posted : June 2, 2022
Sponsor:
Collaborators:
Anticancer Fund, Belgium
Bristol-Myers Squibb
CTD-CNO
ECS-Progastrin SA
Information provided by (Responsible Party):
Centre Oscar Lambret

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2025
Estimated Study Completion Date : January 2028